Skip to content
  • Sunday, 26 July 2026
  • 2:54 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • FDA Approves Four Groundbreaking Cancer Drugs in May, Offering New Hope for Hematological and Solid Tumors
Pharmaceutical R&D

FDA Approves Four Groundbreaking Cancer Drugs in May, Offering New Hope for Hematological and Solid Tumors

Teuku Ryan May 14, 2026 0

The U.S. Food and Drug Administration (FDA) has authorized four significant new cancer drugs in May 2026, marking a pivotal…

Read More
Stem Cell & Regenerative Medicine

Brain Tumors Induce Widespread disruption of Calvarial Bone and Alteration of Skull Marrow Immune Landscape

Dwi Wanna May 9, 2026 0

Researchers from the Montefiore Einstein Comprehensive Cancer Center (MECCC) and the Albert Einstein College of Medicine have unveiled a paradigm-shifting…

Read More
Stem Cell & Regenerative Medicine

Brain Tumors Induce Widespread disruption of Calvarial Bone and Alteration of Skull Marrow Immune Landscape.

Dwi Wanna Apr 25, 2026 0

Researchers from the Montefiore Einstein Comprehensive Cancer Center (MECCC) and the Albert Einstein College of Medicine have fundamentally challenged the…

Read More
Stem Cell & Regenerative Medicine

Brain Tumors Induce Widespread Disruption of Calvarial Bone and Alteration of Skull Marrow Immune Landscape

Dwi Wanna Apr 17, 2026 0

A groundbreaking study led by researchers from the Montefiore Einstein Comprehensive Cancer Center (MECCC) and the Albert Einstein College of…

Read More
Neuroscience & Brain Research

Canadian Researchers Identify Potential HIV Drug Repurposing to Combat Aggressive Glioblastoma Brain Tumors

Rifan Muazin Apr 16, 2026 0

In a landmark study that could redefine the treatment landscape for terminal brain cancer, a collaborative team of Canadian scientists…

Read More
Pharmaceutical R&D

Bristol Myers Squibb and Oxford BioTherapeutics Forge Alliance to Pioneer Novel T-Cell Engager Therapies for Solid Tumors

Teuku Ryan Apr 11, 2026 0

Bristol Myers Squibb (BMS) and Oxford BioTherapeutics (OBT) have announced a significant strategic alliance aimed at discovering and developing a…

Read More
Stem Cell & Regenerative Medicine

Glioblastoma Research Reveals Skull Bone Erosion and Immune System Manipulation by Aggressive Brain Tumors

Dwi Wanna Apr 10, 2026 0

In a landmark study published on October 3 in the journal Nature Neuroscience, researchers from the Montefiore Einstein Comprehensive Cancer…

Read More
Biotech & Genetic Research

Transforming immune cells into cancer-seeking ‘bloodhounds’ to eliminate tumors

Jia Lissa Apr 3, 2026 0

A groundbreaking study by Stanford Medicine researchers has unveiled a novel immunotherapy approach that could revolutionize the treatment of solid…

Read More
Stem Cell & Regenerative Medicine

Glioblastoma Beyond the Brain: Study Reveals How Lethal Tumors Reshape the Skull and Hijack the Immune System to Fuel Aggression

Dwi Wanna Mar 26, 2026 0

The traditional understanding of glioblastoma—a devastating and primary form of brain cancer—has long characterized the disease as a localized phenomenon,…

Read More
Stem Cell & Regenerative Medicine

Brain Tumors Induce Widespread disruption of Calvarial Bone and Alteration of Skull Marrow Immune Landscape

Dwi Wanna Mar 19, 2026 0

The findings from a landmark study conducted by researchers at the Montefiore Einstein Comprehensive Cancer Center (MECCC) and the Albert…

Read More

Posts pagination

1 2
Breakthrough in PFAS Degradation Scientists Identify Hydrogen Radicals as Key to Destroying Forever Chemicals Using UV LightFungal gene editing world-first points to promising cancer medicinesInsilico CEO Sees Potentially $2.75 Billion Collaboration as ‘Fusing Lilly’s Clinical Excellence’ with Insilico’s ‘End-to-End AI Engine’Building a Minimal Feature Store: A Foundational Approach for Modern AI and Machine Learning Infrastructure
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ